Novo Nordisk and UofT announce joint funding to handle diabetes & continual illness prevention

0
565

Novo Nordisk A / S and the University of Toronto (UofT) have announced a $ 40 million investment to build the Novo Nordisk network for healthy populations, according to a press release.

The network will focus on new ways to help healthier urban populations fight the global fight against diabetes and other serious chronic diseases. The new network will be a partnership between the Dalla Lana School of Public Health, the Temerty Faculty of Medicine and the University of Toronto Mississauga.

For the latest news, check out The Daily Star’s Google News channel.

“To mark the 100th anniversary of the discovery of insulin at UofT, we are delighted to be working again with Novo Nordisk, a company that understands the critical importance of helping people with diabetes and other chronic diseases,” said UofT President Meric Gertler.

In 1921, a UofT research team led by Frederick Banting, Charles Best, JJR MacLeod, and James Bertram Collip discovered insulin. Novo Nordisk’s predecessors, Nordisk Insulin Laboratory and Novo Terapeutisk Laboratory, were among the first to produce insulin on a large scale, bringing this life-saving treatment from UofT laboratories to people with diabetes around the world.

Now, 100 years later, UofT and Novo Nordisk will work together again to improve the lives of people with diabetes.